Chao Xu

Hebei Medical University — China

Medicine · Health Sciences

34h-index6.4kcitations296works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Ischemic Stroke Management(23), RNA modifications and cancer(22), Bioinformatics and Genomic Networks(21), Chronic Lymphocytic Leukemia Research(19), Ferroptosis and cancer prognosis(19)

Publications296 total

A multi-omics approach to identify prognostic subtypes and therapeutic targets in head and neck squamous cell carcinoma
2025Open Access
Clinical and genetic study of a family with epidermolysis bullosa simplex caused by a novel <i>KRT5</i> gene mutation c.987C>G (p.Asn329Lys)
Intractable & Rare Diseases Research·2025Open Access
Development of a radiomics-3D deep learning fusion model for prognostic prediction in pancreatic cancer
BMC Cancer·2025· 1 citedOpen Access
ERβ/circAHNAK Axis Inhibits USP10–FMR1 Deubiquitination to Prevent m⁶A‐Mediated ADAM17 Decay and Promote Angiogenesis in Clear Cell Renal Cell Carcinoma
Advanced Science·2025Open Access
Enhancing mRNA therapy through iterative delivery
Science Advances·2025Open Access
Comparative Effectiveness and Safety of Second-Generation Antihistamines Treatments for Chronic Urticaria: A Network Meta-Analysis
International Archives of Allergy and Immunology·2025
Research progress of coronavirus reverse genetics technology
2025Open Access
Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Supplementary Table S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Data from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Figure 4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
The development of a multimodal prediction model based on CT and MRI for the prognosis of pancreatic cancer
BMC Gastroenterology·2025Open Access
Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
Dietary vitamin E intake is associated with lower mortality among individuals with metabolic dysfunction-associated steatotic liver disease
Nutrition Research·2025· 1 cited
Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
2025Open Access
page 1 of 15Next →

Frequent Co-authors

Hong‐Wen Deng(12), Mingyang Liu(6), Jingxuan Yang(6), Zhijun Zhou(6), Xiuhui Shi(6), Wenyi Luo(5), Kar‐Ming Fung(5), Courtney W. Houchen(5), Min Li(5), Jigang Zhang(5), Anna Rodina(4), Tai Wang(4), Tony Taldone(4), Hediye Erdjument‐Bromage(4), Gabriela Chiosis(4), Michael S. Bronze(4), Hui Shen(4), Yu‐Ping Wang(4), Pengrong Yan(3), Mary L. Alpaugh(3)